Wall Street Analysts Believe Monte Rosa Therapeutics (GLUE) Could Rally 67.24%: Here's is How to Trade

Shares of Monte Rosa Therapeutics (GLUE) have gained 76.8% over the past four weeks to close the last trading session at $9.37, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$15.67 indicates a potential upside of 67.2%. The average comprises six short-term price targets ranging from a low of $7 to a high of$20, with a standard deviation of $4.80. While the lowest estimate ind ...